News >

The Rapidly Changing Landscape in RCC Therapy: What Future Research May Hold

Bradley Carthon, MD, PhD
Published: Wednesday, Oct 24, 2018

Bradley Carthon, MD, PhD

Bradley Carthon, MD, PhD

Assistant Professor

Department of Hematology and Medical Oncology

Emory University School of Medicine
Approximately 43,000 cases of kidney cancer in men and 23,000 cases in women will occur in the United States in 2018.1 Almost 90% of those cases will be renal cell carcinoma (RCC), generally affecting individuals between the ages of 50 and 70.1,2 There are varying histologies that make up RCC, with clear cell histology being the most common, accounting for 70% of all cases.2 No singular cause of kidney cancer, including RCC, is known.2 However, certain risk factors have been identified, including obesity, smoking, environmental exposures and family history or genetics.2
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x